Next Article in Journal
Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
Next Article in Special Issue
Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome
Previous Article in Journal
Treatment-Related Adverse Events of Combination EGFR Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor in EGFR-Mutant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases—A Possible Association with High Rheumatoid Arthritis Disease Activity
 
 
Review

Article Versions Notes

Cancers 2022, 14(9), 2158; https://doi.org/10.3390/cancers14092158
Action Date Notes Link
article xml file uploaded 26 April 2022 11:36 CEST Original file -
article xml uploaded. 26 April 2022 11:36 CEST Update https://www.mdpi.com/2072-6694/14/9/2158/xml
article pdf uploaded. 26 April 2022 11:36 CEST Version of Record https://www.mdpi.com/2072-6694/14/9/2158/pdf
article html file updated 26 April 2022 11:37 CEST Original file -
article html file updated 2 August 2022 20:51 CEST Update https://www.mdpi.com/2072-6694/14/9/2158/html
Back to TopTop